pharmacology
Many people want to give trial drugs a chance to save their lives. Here’s how they’ll have to do it
Terminally ill patients are often willing to take any chance for a cure, even taking unapproved trial drugs. But while the process has been haphazard in the past, a new panel funded by pharmaceutical giant Johnson & Johnson will try to give everyone an equal shot at getting such medications.